Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Fair

Showing results (261-270 of 290) with videos related to

Pageof 29
Sort By:
The Journal of Urology|December 11, 1992
Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumorsD P Wood, H W Herr, G Heller, et al.
The Journal of Urology|March 1, 1987
Endocrine and exocrine profiles of men with testicular tumors before orchiectomyP R Carroll, W F Whitmore, H W Herr, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantationZ Fuks, S A Leibel, K E Wallner, et al.
British Journal of Urology|March 1, 1997
Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II studyM S Cookson, P C Sogani, P Russo, et al.
The Journal of Urology|May 1, 1995
TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49P C Brenner, W J Rettig, M P Sanz-Moncasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancerR A Badalament, H W Herr, G Y Wong, et al.
The Journal of Urology|March 1, 1995
Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reactionR S Israeli, W H Miller, S L Su, et al.
The Journal of Urology|August 1, 1994
Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladderA S Sarkis, G Dalbagni, C Cordon-Cardo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancerZ F Zhang, A S Sarkis, C Cordon-Cardo, et al.
Urology|October 1, 1994
The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancerE D Crawford, J M Kozlowski, F M Debruyne, et al.
Pageof 29

Showing results (261-270 of 290) with videos related to

Sort By:
Pageof 29
The Journal of Urology|December 11, 1992
Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumorsD P Wood, H W Herr, G Heller, et al.
The Journal of Urology|March 1, 1987
Endocrine and exocrine profiles of men with testicular tumors before orchiectomyP R Carroll, W F Whitmore, H W Herr, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantationZ Fuks, S A Leibel, K E Wallner, et al.
British Journal of Urology|March 1, 1997
Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II studyM S Cookson, P C Sogani, P Russo, et al.
The Journal of Urology|May 1, 1995
TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49P C Brenner, W J Rettig, M P Sanz-Moncasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancerR A Badalament, H W Herr, G Y Wong, et al.
The Journal of Urology|March 1, 1995
Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reactionR S Israeli, W H Miller, S L Su, et al.
The Journal of Urology|August 1, 1994
Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladderA S Sarkis, G Dalbagni, C Cordon-Cardo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancerZ F Zhang, A S Sarkis, C Cordon-Cardo, et al.
Urology|October 1, 1994
The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancerE D Crawford, J M Kozlowski, F M Debruyne, et al.
Pageof 29